Literature DB >> 4094096

Clonogenic patterns of human pulmonary adenocarcinoma cell lines (PC-9, PC-13 and PC-14) and how they influence the results of test for chemosensitivity to cisplatin in the human tumor clonogenic assay.

Y C Lee, N Saijo, Y Sasaki, H Takahashi, M Sakurai, J Ishihara, A Hoshi, K M Chen, A W Hamburger.   

Abstract

The clonogenic patterns of three human pulmonary adenocarcinoma cell lines (PC-9, PC-13 and PC-14) were studied by human tumor clonogenic assay (HTCA), and factors which could influence the results of tests for the chemosensitivity of these tumor cells to cisplatin in HTCA were determined. The results showed that each tumor cell line had a characteristic clonogenic pattern. The time intervals for the cells to grow to the plateau phase varied from 9 to 16 days, depending on the cell line and number of cells plated. The number of cells plated could substantially influence the results of chemosensitivity tests. The percentage of surviving colonies increased markedly if too many cells (usually 5 X 10(4) or more/plate) were plated. For continuous exposure, the results of chemosensitivity tests were rather stable after 7 days of incubation in each cell line, especially when fewer than 2 X 10(4) cells/plate were plated. For 1-hour exposure, the incubation periods for the results to become stable varied from 7 to 16 days depending on the cell type, number of cells plated and drug concentration. It was stressed that for the correct evaluation of the chemosensitivity of cultured cell lines in HTCA, the clonogenic pattern of each tumor cell line should be checked in detail before further experiments are conducted. The higher the concentration and the longer the exposure time, the more strongly cis-diamminedichloroplatinum (CDDP) suppressed the colony growth in each of the three cell lines in HTCA, and it was recommended that CDDP should be used clinically in such a way as to maintain a high serum level of the active form of CDDP for a long time.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4094096

Source DB:  PubMed          Journal:  Jpn J Clin Oncol        ISSN: 0368-2811            Impact factor:   3.019


  12 in total

1.  Overexpression of PSAT1 promotes metastasis of lung adenocarcinoma by suppressing the IRF1-IFNγ axis.

Authors:  Yung-Chieh Chan; Yu-Chan Chang; Hsiang-Hao Chuang; Yi-Chieh Yang; Yuan-Feng Lin; Ming-Shyan Huang; Michael Hsiao; Chih-Jen Yang; Kuo-Tai Hua
Journal:  Oncogene       Date:  2020-01-27       Impact factor: 9.867

2.  The colony inhibition of a new chemotherapeutic agent (KW2152) against human lung cancer cell lines.

Authors:  J R Jett; N Saijo; W S Hong; Y Sasaki; H Takahashi; H Nakano; K Nakagawa; M Sakurai; K Suemasu; M Tesada
Journal:  Invest New Drugs       Date:  1987       Impact factor: 3.850

3.  In vitro antitumor effect of recombinant human tumor necrotizing factor on cultured human cancer cell lines and freshly isolated lung cancer cells by the human tumor clonogenic assay.

Authors:  Y Sasaki; F Kanzawa; H Takahashi; Y Matsushima; H Nakano; K Nakagawa; W S Hong; K Minato; Y Fujiwara; N Saijo
Journal:  Invest New Drugs       Date:  1987-12       Impact factor: 3.850

4.  Production of transforming growth factor-alpha in human tumour cell lines.

Authors:  K Imanishi; K Yamaguchi; M Suzuki; S Honda; N Yanaihara; K Abe
Journal:  Br J Cancer       Date:  1989-05       Impact factor: 7.640

5.  The nucleolar protein NIFK promotes cancer progression via CK1α/β-catenin in metastasis and Ki-67-dependent cell proliferation.

Authors:  Tsung-Chieh Lin; Chia-Yi Su; Pei-Yu Wu; Tsung-Ching Lai; Wen-An Pan; Yi-Hua Jan; Yu-Chang Chang; Chi-Tai Yeh; Chi-Long Chen; Luo-Ping Ger; Hong-Tai Chang; Chih-Jen Yang; Ming-Shyan Huang; Yu-Peng Liu; Yuan-Feng Lin; John Y-J Shyy; Ming-Daw Tsai; Michael Hsiao
Journal:  Elife       Date:  2016-03-17       Impact factor: 8.140

6.  GIT1 promotes lung cancer cell metastasis through modulating Rac1/Cdc42 activity and is associated with poor prognosis.

Authors:  Jeng-Shou Chang; Chia-Yi Su; Wen-Hsuan Yu; Wei-Jiunn Lee; Yu-Peng Liu; Tsung-Ching Lai; Yi-Hua Jan; Yi-Fang Yang; Chia-Ning Shen; Jin-Yuh Shew; Jean Lu; Chih-Jen Yang; Ming-Shyan Huang; Pei-Jung Lu; Yuan-Feng Lin; Min-Liang Kuo; Kuo-Tai Hua; Michael Hsiao
Journal:  Oncotarget       Date:  2015-11-03

7.  Expression of the Wilms' tumor gene WT1 in solid tumors and its involvement in tumor cell growth.

Authors:  Y Oji; H Ogawa; H Tamaki; Y Oka; A Tsuboi; E H Kim; T Soma; T Tatekawa; M Kawakami; M Asada; T Kishimoto; H Sugiyama
Journal:  Jpn J Cancer Res       Date:  1999-02

8.  Downregulating CD26/DPPIV by apigenin modulates the interplay between Akt and Snail/Slug signaling to restrain metastasis of lung cancer with multiple EGFR statuses.

Authors:  Jer-Hwa Chang; Chao-Wen Cheng; Yi-Chieh Yang; Wan-Shen Chen; Wen-Yueh Hung; Jyh-Ming Chow; Pai-Sheng Chen; Michael Hsiao; Wei-Jiunn Lee; Ming-Hsien Chien
Journal:  J Exp Clin Cancer Res       Date:  2018-08-22

9.  Pin1 coordinates HDAC6 upregulation with cell migration in lung cancer cells.

Authors:  Hsiang-Hao Chuang; Jui-Feng Hsu; Hsu-Liang Chang; Pei-Hui Wang; Po-Ju Wei; Da-Wei Wu; Ming-Shyan Huang; Michael Hsiao; Chih-Jen Yang
Journal:  Int J Med Sci       Date:  2020-09-21       Impact factor: 3.738

10.  Decrease of FSTL1-BMP4-Smad signaling predicts poor prognosis in lung adenocarcinoma but not in squamous cell carcinoma.

Authors:  Jean Chiou; Chia-Yi Su; Yi-Hua Jan; Chih-Jen Yang; Ming-Shyan Huang; Yung-Luen Yu; Michael Hsiao
Journal:  Sci Rep       Date:  2017-08-29       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.